Fmr LLC Acadia Pharmaceuticals Inc Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Fmr LLC holds 169,362 shares of ACAD stock, worth $3.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

169,362

Previous 174,251 2.81%

Holding current value

$3.45 Million

Previous $2.89 Million 26.23%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$14.1 - $22.95 $68,934 - $112,202	-4,889 Reduced 2.81%	169,362 $3.65 Million
Q1 2025 May 12, 2025	BUY	$16.61 - $20.29 $601,713 - $735,025	36,226 Added 26.25%	174,251 $2.89 Million
Q4 2024 Feb 13, 2025	BUY	$14.29 - $18.76 $581,131 - $762,912	40,667 Added 41.77%	138,025 $2.53 Million
Q3 2024 Nov 13, 2024	SELL	$15.14 - $19.14 $34.4 Million - $43.4 Million	-2,269,618 Reduced 95.89%	97,358 $1.5 Million
Q2 2024 Aug 13, 2024	SELL	$14.62 - $18.42 $23.8 Million - $30 Million	-1,626,830 Reduced 40.73%	2,366,976 $38.5 Million
Q1 2024 May 13, 2024	SELL	$17.79 - $30.86 $22.6 Million - $39.2 Million	-1,271,552 Reduced 24.15%	3,993,806 $73.8 Million
Q4 2023 Feb 13, 2024	SELL	$20.78 - $31.77 $761,005 - $1.16 Million	-36,622 Reduced 0.69%	5,265,358 $165 Million
Q3 2023 Nov 13, 2023	SELL	$20.84 - $33.47 $401,315 - $644,531	-19,257 Reduced 0.36%	5,301,980 $110 Million
Q2 2023 Aug 11, 2023	SELL	$17.8 - $25.65 $45 Million - $64.8 Million	-2,525,436 Reduced 32.18%	5,321,237 $127 Million
Q1 2023 May 11, 2023	SELL	$16.32 - $20.92 $24.3 Million - $31.1 Million	-1,487,941 Reduced 15.94%	7,846,673 $148 Million
Q4 2022 Feb 13, 2023	SELL	$14.2 - $18.63 $31.8 Million - $41.7 Million	-2,236,411 Reduced 19.33%	9,334,614 $149 Million
Q3 2022 Nov 10, 2022	SELL	$14.11 - $18.27 $11.7 Million - $15.1 Million	-827,932 Reduced 6.68%	11,571,025 $189 Million
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $14.1 Million - $29.5 Million	-1,082,492 Reduced 8.03%	12,398,957 $175 Million
Q1 2022 May 13, 2022	SELL	$20.94 - $27.5 $7.52 Million - $9.88 Million	-359,301 Reduced 2.6%	13,481,449 $327 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $34.2 Million - $55.1 Million	-2,035,794 Reduced 12.82%	13,840,750 $323 Million
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $5.96 Million - $9.35 Million	377,406 Added 2.44%	15,876,544 $0
Q2 2021 Aug 13, 2021	BUY	$19.4 - $27.42 $301 Million - $425 Million	15,499,138 New	15,499,138 $0

Others Institutions Holding ACAD

# of Institutions

348

Shares Held

163M

Call Options Held

811K

Put Options Held

334K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.3B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account